Low levels of ionic mercury modulate protein tyrosine phosphorylation in lymphocytes

International Journal of Immunopharmacology

Volumn 20, Issue 12, 1998, Pages 697-707

  Rosenspire, A J ^a   Bodepudi, S ^a   Mathews, M ^a   McCabe Jr , M J ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Lymphocyte; Mercury; Protein tyrosine phosphorylation; Signal transduction

Indexed keywords

DISULFIDE; MERCURY; PENICILLAMINE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; IMMUNE SYSTEM; LYMPHOCYTE; MERCURIALISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPLEEN CELL; TOXICITY TESTING;

ANIMALS; B-LYMPHOCYTES; CATIONS, DIVALENT; CHELATING AGENTS; ETHYLMALEIMIDE; LYMPHOMA, B-CELL; MERCURY; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; PENICILLAMINE; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOTYROSINE; SPLEEN; SULFHYDRYL REAGENTS; TUMOR CELLS, CULTURED;

EID: 0031739270     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(98)00045-9     Document Type: Article

References (32)

1. Al-Balaghi S., Moller E., Moller G., Abedi-Valugerdi M. Eur. J. Immunol. 26:1996;1519-1526.
2. Barr R.D. East Afr. Med. J. 67:1990;381-386.
3. Benhamou L.E., Watanabe T., Kitamura D., Cazenave P.-A., Sarthou P. Eur. J. Immunol. 24:1994;1993-1999.
4. Bigazzi P.E. Immunol. Immunopathol. 65:1992;81-84.
5. Boyd A.W., Schrader J.W. II. The inhibition of WEHI. 126:1981;2466-2469.
6. Cambier J.C., Pleiman C.M., Clark M.R. Annu. Rev. Immunol. 12:1994;457-486.
7. Cambier J.C., Bedzyk W., Campbell K., Chien N., Friedrich J., Harwood A., Jensen W., Pleiman C., Clark M.R. Immunol. Rev. 132:1994;85-106.
8. Chan A.C., Desai D.M., Weiss A. Annu. Rev. Immunol. 12:1994;555-592.
9. Dantas D.C.M., Queiroz M.L.S. Immunopharmacol. Immunotoxicol. 19:1997;383-392.
10. Daum J.R., Shepherd D.M., Noelle R.J. I. Effects on lymphocyte function. 15:1993;383-394.
11. Duncan D.D., Lawrence D.A. Toxicol. Appl. Pharmacol. 100:1989;485-497.
12. Freed B.M., Lempert N., Lawrence D.A. Toxicol. Appl. Pharmacol. 107:1991;173-182.
13. Gerstner H.B., Huff J.E. J. Toxicol. Environ. Health. 2:1977;491-526.
14. Gold M.R., Law D.A., DeFranco A.L. Nature (London). 345:1990;810-813.
15. Griffiths D.G., Partis M.D., Sharp R.N., Beechey R.B. FEBS Lett. 134:1981;261-263.
16. Hua J., Pelletier L., Berlin M., Druet P. Toxicology. 79:1993;119-129.
17. Hultman P., Enestrom S. Toxicol. Appl. Pharmacol. 113:1992;199-208.
18. Jiang Y.J., Moller G. J. Immunol. 154:1995;3138-3146.
19. Lawrence D.A. Toxicol. Appl. Pharmacol. 57:1981;439-451.
20. Nakashima I., Pu M.-Y., Nishizaki A., Rosila I., Ma L., Katano Y., Ohkusu K., Rahman S.H.J., Isobe K., Hamaguchi M., Saga K. J. Immunol. 152:1994;1064-1071.
21. Page D.M., DeFranco A.L. J. Immunol. 140:1988;3717-3726.
22. Perlingeiro R.C.R., Queiroz M.L.S. Int. J. Immunopharmac. 16:1994;1011-1017.
23. Queiroz M.L.S., Dantas D.C.M. Immunopharmacol. Immunotoxicol. 19:1997;499-510.
24. Queiroz M.L.S., Dantas D.C.M. Pharmacol. Toxicol. 81:1997;130-133.
25. Queiroz M.L.S., Perlingeiro R.C.R., Dantas D.C.M., Annichino Bizzacchi J.M., De Capitani E.M. Pharmacol. Toxicol. 74:1994;72-75.
26. Ratcliffe H.E., Swanson G.M., Fischer L.J. J. Toxicol. Environ. Health. 49:1996;221-270.
27. Roger J., Zillikens D., Burg G., Gleichmann E. Eur. J. Dermatol. 2:1992;168-170.
28. Rosenspire, A.J., McCabe, M., Bodepudi, S., Alhasan, S., 1995. Effect of sulfhydryl reactive reagents on lymphocyte tyrosine phosphorylation and signal transduction. 9th International Congress of Immunology. Abstract.
29. Schrallhammer-Benkler K., Ring J., Przybila B., Meurer M., Landthaler M. Acta Dermato-Venerol. 72:1992;294-296.
30. Shenker B.J., Rooney C., Vitale L., Shapiro I.M. Immunopharmacol. Immunotoxicol. 14:1992;539-553.
31. Shenker B.J., Berthold P., Rooney C., Vitale L., DeBolt K., Shapiro I.M. Immunopharmacol. Immunotoxicol. 15:1993;87-112.
32. Weiss A. Cell. 73:1993;209-212.